Lacosamide-induced sinus node dysfunction followed by severe agranulocytosis

Lacosamide (LCM) is the antiepileptic drug approved by the U.S. Food and Drug Administration in 2008 that facilitates slow activation of the voltage-gated sodium channels. Neutropenia and cardiac events includ...

Source: BMC Neurology - June 8, 2021 Category: Neurology Authors: Makoto Shibata, Reona Hoshino, Chisato Shimizu, Masayuki Sato, Natsumi Furuta and Yoshio Ikeda Tags: Case report Source Type: research